Ir para o conteúdo principal

Crypto Financial

Bloomberg
Financial

Ukraine to Resume Russia Refinery Strikes, Defying Trump

Ukrainian President Volodymyr Zelenskyy has ordered attacks on Russian oil refineries to resume, ending a three-day pause on strikes in response to US President Donald Trump's call last week for an "energy ceasefire." Moscow has continued attacking Ukrainian energy infrastructure and civilian targets over the last few days leading to a mounting death toll. Tony Halpin reports on Bloomberg Television.

Leia mais: Ukraine to Resume Russia Refinery Strikes, Defying Trump
Bloomberg
Financial

Healey Says Budget Will Protect UK Economic 'Resilience'

Chancellor of the Exchequer John Healey discusses the International Monetary Fund's comments that the UK is the "country that basically stands out" for plotting a path to bring down borrowing. Speaking to Bloomberg's Lisa Abramowicz in Bangkok, Healey also discusses the importance of banks to the British economy, declining to comment on potential tax measures in the government's Oct. 28 budget. (Corrects spelling of guest's name in headline.)

Leia mais: Healey Says Budget Will Protect UK Economic 'Resilience'
Bloomberg
Financial

Healy Says Budget Will Protect UK Economic 'Resilience'

Chancellor of the Exchequer John Healey discusses the International Monetary Fund's comments that the UK is the "country that basically stands out" for plotting a path to bring down borrowing. Speaking to Bloomberg's Lisa Abramowicz in Bangkok, Healey also discusses the importance of banks to the British economy, declining to comment on potential tax measures in the government's Oct. 28 budget.

Leia mais: Healy Says Budget Will Protect UK Economic 'Resilience'
Bloomberg
Financial

Vontobel Co-CEO: Higher Rates Not a Problem per Se, Pace Can Be

Christel Rendu De Lint, Co-CEO of Vontobel, on AI, cyber risks and if UBS left Switzerland. 'I would prefer them to stay. It's a brand for the Swiss economy, losing a major brand, a major actor, it's a loss'. She speaks on Bloomberg's "The Opening Trade" with Anna Edwards, Guy Johnson and Tom Mackenzie.

Leia mais: Vontobel Co-CEO: Higher Rates Not a Problem per Se, Pace Can Be
Bloomberg
Financial

Souaid: IMF Lebanon Talks Progressing At 'Good Pace'

Lebanese Central Bank Governor Karim Souaid said talks with the IMF are progressing at a good pace. This comes as the country commenced high level negotiations with the Fund on the sidelines of the IMF-World Bank meetings in Bangkok. Souaid spoke exclusively to Bloomberg's Avril Hong on Horizons Middle East & Africa.

Leia mais: Souaid: IMF Lebanon Talks Progressing At 'Good Pace'
Bloomberg
Financial

Semiconductor Research Head: AI Trade 'Remarkably Resilient' Despite Rising Rates

Technology Hardware and Semiconductor Research Head at Rothschild & Co Redburn Timm Schulze-Melander joins Bloomberg's Anna Edwards and Guy Johnson. "We are in the middle of a very powerful platform change and so far it has actually proven very resilient to rising rates, to supply-demand constraints, etc. It's been remarkably resilient," he says on "The Opening Trade."

Leia mais: Semiconductor Research Head: AI Trade 'Remarkably Resilient' Despite Rising Rates
Bloomberg
Financial

Deutsche Bank Sees 'Promising' Signs in Limited Selloff

Henry Allen, macro strategist at Deutsche Bank Research, discusses market moves as a selloff in the artificial intelligence trade gathered speed. "If it was a concern, we'd be seeing broader stock market see bigger falls," he tells Bloomberg Television. "The fact that we haven't seen that spread to Europe, for instance, we haven't seen that contagion, that slowdown elsewhere, I think is a promising sign," Allen adds.

Leia mais: Deutsche Bank Sees 'Promising' Signs in Limited Selloff
Bloomberg
Financial

Biocon Chair: AI in Clinical Trials Is the Holy Grail

Biocon Executive Chairperson Kiran Mazumdar-Shaw told Bloomberg's Francine Lacqua that a wave of expiring biologic patents provides a major runway to expand affordable cancer biosimilars and elevate the company above its current top-five global ranking. Speaking on the sidelines of the Bloomberg New Economy Forum in New Delhi, Mazumdar-Shaw added that while AI accelerates molecular discovery, the true "holy grail" is using the technology to abbreviate long, expensive clinical trials by predicting safety and efficacy.

Leia mais: Biocon Chair: AI in Clinical Trials Is the Holy Grail